JPH0120878B2 - - Google Patents
Info
- Publication number
- JPH0120878B2 JPH0120878B2 JP14109781A JP14109781A JPH0120878B2 JP H0120878 B2 JPH0120878 B2 JP H0120878B2 JP 14109781 A JP14109781 A JP 14109781A JP 14109781 A JP14109781 A JP 14109781A JP H0120878 B2 JPH0120878 B2 JP H0120878B2
- Authority
- JP
- Japan
- Prior art keywords
- pseudonocardia
- methanolignica
- medium
- genus
- androstane
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired
Links
- 229930182558 Sterol Natural products 0.000 claims description 15
- 238000000034 method Methods 0.000 claims description 15
- 150000003432 sterols Chemical class 0.000 claims description 15
- 235000003702 sterols Nutrition 0.000 claims description 15
- -1 androstane compound Chemical class 0.000 claims description 8
- 150000001875 compounds Chemical class 0.000 claims description 6
- 244000005700 microbiome Species 0.000 claims description 6
- 238000004519 manufacturing process Methods 0.000 claims description 5
- QZLYKIGBANMMBK-UGCZWRCOSA-N 5α-Androstane Chemical compound C([C@@H]1CC2)CCC[C@]1(C)[C@@H]1[C@@H]2[C@@H]2CCC[C@@]2(C)CC1 QZLYKIGBANMMBK-UGCZWRCOSA-N 0.000 claims description 4
- BTTWKVFKBPAFDK-UHFFFAOYSA-N (9beta,10alpha)-Androst-4-ene-3,17-dione Natural products OC1CCC2(C)C3CCC(C)(C(CC4)O)C4C3CCC2=C1 BTTWKVFKBPAFDK-UHFFFAOYSA-N 0.000 claims description 2
- AEMFNILZOJDQLW-QAGGRKNESA-N androst-4-ene-3,17-dione Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CCC2=C1 AEMFNILZOJDQLW-QAGGRKNESA-N 0.000 claims description 2
- AEMFNILZOJDQLW-UHFFFAOYSA-N androstenedione Natural products O=C1CCC2(C)C3CCC(C)(C(CC4)=O)C4C3CCC2=C1 AEMFNILZOJDQLW-UHFFFAOYSA-N 0.000 claims description 2
- OSVMTWJCGUFAOD-KZQROQTASA-N formestane Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CCC2=C1O OSVMTWJCGUFAOD-KZQROQTASA-N 0.000 claims 1
- OKKJLVBELUTLKV-UHFFFAOYSA-N Methanol Chemical compound OC OKKJLVBELUTLKV-UHFFFAOYSA-N 0.000 description 33
- 239000002609 medium Substances 0.000 description 28
- 230000012010 growth Effects 0.000 description 18
- 241000187603 Pseudonocardia Species 0.000 description 17
- 229920001817 Agar Polymers 0.000 description 12
- XEKOWRVHYACXOJ-UHFFFAOYSA-N Ethyl acetate Chemical compound CCOC(C)=O XEKOWRVHYACXOJ-UHFFFAOYSA-N 0.000 description 12
- 239000008272 agar Substances 0.000 description 12
- HVYWMOMLDIMFJA-DPAQBDIFSA-N cholesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 HVYWMOMLDIMFJA-DPAQBDIFSA-N 0.000 description 12
- 150000001441 androstanes Chemical class 0.000 description 10
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 9
- 239000000049 pigment Substances 0.000 description 9
- ROFVEXUMMXZLPA-UHFFFAOYSA-N Bipyridyl Chemical group N1=CC=CC=C1C1=CC=CC=N1 ROFVEXUMMXZLPA-UHFFFAOYSA-N 0.000 description 7
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 description 7
- 230000001580 bacterial effect Effects 0.000 description 7
- 229910052799 carbon Inorganic materials 0.000 description 7
- 230000003647 oxidation Effects 0.000 description 7
- 238000007254 oxidation reaction Methods 0.000 description 7
- 241000186361 Actinobacteria <class> Species 0.000 description 6
- IJGRMHOSHXDMSA-UHFFFAOYSA-N Atomic nitrogen Chemical compound N#N IJGRMHOSHXDMSA-UHFFFAOYSA-N 0.000 description 6
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 description 6
- 235000012000 cholesterol Nutrition 0.000 description 6
- 239000000203 mixture Substances 0.000 description 6
- UHOVQNZJYSORNB-UHFFFAOYSA-N Benzene Chemical compound C1=CC=CC=C1 UHOVQNZJYSORNB-UHFFFAOYSA-N 0.000 description 5
- WQZGKKKJIJFFOK-GASJEMHNSA-N Glucose Natural products OC[C@H]1OC(O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-GASJEMHNSA-N 0.000 description 5
- WQZGKKKJIJFFOK-VFUOTHLCSA-N beta-D-glucose Chemical compound OC[C@H]1O[C@@H](O)[C@H](O)[C@@H](O)[C@@H]1O WQZGKKKJIJFFOK-VFUOTHLCSA-N 0.000 description 5
- LGJMUZUPVCAVPU-UHFFFAOYSA-N beta-Sitostanol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CC)C(C)C)C1(C)CC2 LGJMUZUPVCAVPU-UHFFFAOYSA-N 0.000 description 5
- 210000002421 cell wall Anatomy 0.000 description 5
- 239000008103 glucose Substances 0.000 description 5
- OILXMJHPFNGGTO-UHFFFAOYSA-N (22E)-(24xi)-24-methylcholesta-5,22-dien-3beta-ol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(C)C(C)C)C1(C)CC2 OILXMJHPFNGGTO-UHFFFAOYSA-N 0.000 description 4
- 241000894006 Bacteria Species 0.000 description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- PEDCQBHIVMGVHV-UHFFFAOYSA-N Glycerine Chemical compound OCC(O)CO PEDCQBHIVMGVHV-UHFFFAOYSA-N 0.000 description 4
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 4
- PXHVJJICTQNCMI-UHFFFAOYSA-N Nickel Chemical compound [Ni] PXHVJJICTQNCMI-UHFFFAOYSA-N 0.000 description 4
- 240000004808 Saccharomyces cerevisiae Species 0.000 description 4
- 229940041514 candida albicans extract Drugs 0.000 description 4
- 239000000284 extract Substances 0.000 description 4
- 239000003112 inhibitor Substances 0.000 description 4
- 239000000543 intermediate Substances 0.000 description 4
- VLKZOEOYAKHREP-UHFFFAOYSA-N n-Hexane Chemical compound CCCCCC VLKZOEOYAKHREP-UHFFFAOYSA-N 0.000 description 4
- 239000002994 raw material Substances 0.000 description 4
- 241000894007 species Species 0.000 description 4
- 239000012138 yeast extract Substances 0.000 description 4
- OQMZNAMGEHIHNN-UHFFFAOYSA-N 7-Dehydrostigmasterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CC(CC)C(C)C)CCC33)C)C3=CC=C21 OQMZNAMGEHIHNN-UHFFFAOYSA-N 0.000 description 3
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 3
- SGNBVLSWZMBQTH-FGAXOLDCSA-N Campesterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@H](C(C)C)C)C)CC4)CC3)CC=2)CC1 SGNBVLSWZMBQTH-FGAXOLDCSA-N 0.000 description 3
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 3
- BTEISVKTSQLKST-UHFFFAOYSA-N Haliclonasterol Natural products CC(C=CC(C)C(C)(C)C)C1CCC2C3=CC=C4CC(O)CCC4(C)C3CCC12C BTEISVKTSQLKST-UHFFFAOYSA-N 0.000 description 3
- 241000187654 Nocardia Species 0.000 description 3
- 229920002472 Starch Polymers 0.000 description 3
- NJKOMDUNNDKEAI-UHFFFAOYSA-N beta-sitosterol Natural products CCC(CCC(C)C1CCC2(C)C3CC=C4CC(O)CCC4C3CCC12C)C(C)C NJKOMDUNNDKEAI-UHFFFAOYSA-N 0.000 description 3
- RSIHSRDYCUFFLA-DYKIIFRCSA-N boldenone Chemical compound O=C1C=C[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 RSIHSRDYCUFFLA-DYKIIFRCSA-N 0.000 description 3
- SGNBVLSWZMBQTH-PODYLUTMSA-N campesterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](C)C(C)C)[C@@]1(C)CC2 SGNBVLSWZMBQTH-PODYLUTMSA-N 0.000 description 3
- 235000000431 campesterol Nutrition 0.000 description 3
- 239000002738 chelating agent Substances 0.000 description 3
- 238000012258 culturing Methods 0.000 description 3
- RSIHSRDYCUFFLA-UHFFFAOYSA-N dehydrotestosterone Natural products O=C1C=CC2(C)C3CCC(C)(C(CC4)O)C4C3CCC2=C1 RSIHSRDYCUFFLA-UHFFFAOYSA-N 0.000 description 3
- 239000000975 dye Substances 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 239000008273 gelatin Substances 0.000 description 3
- 229920000159 gelatin Polymers 0.000 description 3
- 239000001963 growth medium Substances 0.000 description 3
- 229910052742 iron Inorganic materials 0.000 description 3
- 229910052757 nitrogen Inorganic materials 0.000 description 3
- 235000015097 nutrients Nutrition 0.000 description 3
- 239000012188 paraffin wax Substances 0.000 description 3
- LWIHDJKSTIGBAC-UHFFFAOYSA-K potassium phosphate Substances [K+].[K+].[K+].[O-]P([O-])([O-])=O LWIHDJKSTIGBAC-UHFFFAOYSA-K 0.000 description 3
- KZJWDPNRJALLNS-VJSFXXLFSA-N sitosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC[C@@H](CC)C(C)C)[C@@]1(C)CC2 KZJWDPNRJALLNS-VJSFXXLFSA-N 0.000 description 3
- 229950005143 sitosterol Drugs 0.000 description 3
- NLQLSVXGSXCXFE-UHFFFAOYSA-N sitosterol Natural products CC=C(/CCC(C)C1CC2C3=CCC4C(C)C(O)CCC4(C)C3CCC2(C)C1)C(C)C NLQLSVXGSXCXFE-UHFFFAOYSA-N 0.000 description 3
- 235000020183 skimmed milk Nutrition 0.000 description 3
- 239000002904 solvent Substances 0.000 description 3
- 239000008107 starch Substances 0.000 description 3
- 235000019698 starch Nutrition 0.000 description 3
- 239000000126 substance Substances 0.000 description 3
- 235000000346 sugar Nutrition 0.000 description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 3
- 230000037303 wrinkles Effects 0.000 description 3
- KZJWDPNRJALLNS-VPUBHVLGSA-N (-)-beta-Sitosterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@@](C)([C@H]([C@H](CC[C@@H](C(C)C)CC)C)CC4)CC3)CC=2)CC1 KZJWDPNRJALLNS-VPUBHVLGSA-N 0.000 description 2
- CSVWWLUMXNHWSU-UHFFFAOYSA-N (22E)-(24xi)-24-ethyl-5alpha-cholest-22-en-3beta-ol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)C=CC(CC)C(C)C)C1(C)CC2 CSVWWLUMXNHWSU-UHFFFAOYSA-N 0.000 description 2
- NADSFPYUTGUROD-GYKMGIIDSA-N (8s,9s,10r,13r,14s,17r)-10,13-dimethyl-17-[(2r)-6-methylhept-3-en-2-yl]-1,2,6,7,8,9,11,12,14,15,16,17-dodecahydrocyclopenta[a]phenanthren-3-one Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)C=CCC(C)C)[C@@]1(C)CC2 NADSFPYUTGUROD-GYKMGIIDSA-N 0.000 description 2
- KLEXDBGYSOIREE-UHFFFAOYSA-N 24xi-n-propylcholesterol Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(CCC)C(C)C)C1(C)CC2 KLEXDBGYSOIREE-UHFFFAOYSA-N 0.000 description 2
- NLXLAEXVIDQMFP-UHFFFAOYSA-N Ammonia chloride Chemical compound [NH4+].[Cl-] NLXLAEXVIDQMFP-UHFFFAOYSA-N 0.000 description 2
- LPZCCMIISIBREI-MTFRKTCUSA-N Citrostadienol Natural products CC=C(CC[C@@H](C)[C@H]1CC[C@H]2C3=CC[C@H]4[C@H](C)[C@@H](O)CC[C@]4(C)[C@H]3CC[C@]12C)C(C)C LPZCCMIISIBREI-MTFRKTCUSA-N 0.000 description 2
- FBPFZTCFMRRESA-KVTDHHQDSA-N D-Mannitol Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)[C@H](O)CO FBPFZTCFMRRESA-KVTDHHQDSA-N 0.000 description 2
- SHZGCJCMOBCMKK-UHFFFAOYSA-N D-mannomethylose Natural products CC1OC(O)C(O)C(O)C1O SHZGCJCMOBCMKK-UHFFFAOYSA-N 0.000 description 2
- ARVGMISWLZPBCH-UHFFFAOYSA-N Dehydro-beta-sitosterol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)CCC(CC)C(C)C)CCC33)C)C3=CC=C21 ARVGMISWLZPBCH-UHFFFAOYSA-N 0.000 description 2
- 108010010803 Gelatin Proteins 0.000 description 2
- DHMQDGOQFOQNFH-UHFFFAOYSA-N Glycine Chemical compound NCC(O)=O DHMQDGOQFOQNFH-UHFFFAOYSA-N 0.000 description 2
- PNNNRSAQSRJVSB-UHFFFAOYSA-N L-rhamnose Natural products CC(O)C(O)C(O)C(O)C=O PNNNRSAQSRJVSB-UHFFFAOYSA-N 0.000 description 2
- OUYCCCASQSFEME-QMMMGPOBSA-N L-tyrosine Chemical compound OC(=O)[C@@H](N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-QMMMGPOBSA-N 0.000 description 2
- 241001467578 Microbacterium Species 0.000 description 2
- 229910002651 NO3 Inorganic materials 0.000 description 2
- NHNBFGGVMKEFGY-UHFFFAOYSA-N Nitrate Chemical compound [O-][N+]([O-])=O NHNBFGGVMKEFGY-UHFFFAOYSA-N 0.000 description 2
- 239000001888 Peptone Substances 0.000 description 2
- 108010080698 Peptones Proteins 0.000 description 2
- RJKFOVLPORLFTN-LEKSSAKUSA-N Progesterone Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 RJKFOVLPORLFTN-LEKSSAKUSA-N 0.000 description 2
- 241000452114 Pseudonocardia spinosa Species 0.000 description 2
- MUMGGOZAMZWBJJ-DYKIIFRCSA-N Testostosterone Chemical compound O=C1CC[C@]2(C)[C@H]3CC[C@](C)([C@H](CC4)O)[C@@H]4[C@@H]3CCC2=C1 MUMGGOZAMZWBJJ-DYKIIFRCSA-N 0.000 description 2
- HZYXFRGVBOPPNZ-UHFFFAOYSA-N UNPD88870 Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)=CCC(CC)C(C)C)C1(C)CC2 HZYXFRGVBOPPNZ-UHFFFAOYSA-N 0.000 description 2
- 150000001298 alcohols Chemical class 0.000 description 2
- 239000002518 antifoaming agent Substances 0.000 description 2
- SRBFZHDQGSBBOR-UHFFFAOYSA-N beta-D-Pyranose-Lyxose Natural products OC1COC(O)C(O)C1O SRBFZHDQGSBBOR-UHFFFAOYSA-N 0.000 description 2
- MJVXAPPOFPTTCA-UHFFFAOYSA-N beta-Sistosterol Natural products CCC(CCC(C)C1CCC2C3CC=C4C(C)C(O)CCC4(C)C3CCC12C)C(C)C MJVXAPPOFPTTCA-UHFFFAOYSA-N 0.000 description 2
- 229910052793 cadmium Inorganic materials 0.000 description 2
- BDOSMKKIYDKNTQ-UHFFFAOYSA-N cadmium atom Chemical compound [Cd] BDOSMKKIYDKNTQ-UHFFFAOYSA-N 0.000 description 2
- 210000004027 cell Anatomy 0.000 description 2
- 238000006243 chemical reaction Methods 0.000 description 2
- AARSTNLEOKIRTL-GYKMGIIDSA-N cholest-1,4-dien-3-one Chemical compound C1CC2=CC(=O)C=C[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 AARSTNLEOKIRTL-GYKMGIIDSA-N 0.000 description 2
- 229910017052 cobalt Inorganic materials 0.000 description 2
- 239000010941 cobalt Substances 0.000 description 2
- GUTLYIVDDKVIGB-UHFFFAOYSA-N cobalt atom Chemical compound [Co] GUTLYIVDDKVIGB-UHFFFAOYSA-N 0.000 description 2
- 238000000354 decomposition reaction Methods 0.000 description 2
- QBSJHOGDIUQWTH-UHFFFAOYSA-N dihydrolanosterol Natural products CC(C)CCCC(C)C1CCC2(C)C3=C(CCC12C)C4(C)CCC(C)(O)C(C)(C)C4CC3 QBSJHOGDIUQWTH-UHFFFAOYSA-N 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000004817 gas chromatography Methods 0.000 description 2
- 235000019322 gelatine Nutrition 0.000 description 2
- 235000011852 gelatine desserts Nutrition 0.000 description 2
- 235000011187 glycerol Nutrition 0.000 description 2
- 238000004128 high performance liquid chromatography Methods 0.000 description 2
- 229910017053 inorganic salt Inorganic materials 0.000 description 2
- 238000002955 isolation Methods 0.000 description 2
- TWBYWOBDOCUKOW-UHFFFAOYSA-N isonicotinic acid Chemical compound OC(=O)C1=CC=NC=C1 TWBYWOBDOCUKOW-UHFFFAOYSA-N 0.000 description 2
- 239000007788 liquid Substances 0.000 description 2
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 2
- 235000019341 magnesium sulphate Nutrition 0.000 description 2
- 230000000813 microbial effect Effects 0.000 description 2
- 230000000877 morphologic effect Effects 0.000 description 2
- 229910052759 nickel Inorganic materials 0.000 description 2
- 239000003921 oil Substances 0.000 description 2
- 235000019198 oils Nutrition 0.000 description 2
- 239000003960 organic solvent Substances 0.000 description 2
- 235000019319 peptone Nutrition 0.000 description 2
- 230000001766 physiological effect Effects 0.000 description 2
- BASFCYQUMIYNBI-UHFFFAOYSA-N platinum Chemical compound [Pt] BASFCYQUMIYNBI-UHFFFAOYSA-N 0.000 description 2
- MUPFEKGTMRGPLJ-ZQSKZDJDSA-N raffinose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO[C@@H]2[C@@H]([C@@H](O)[C@@H](O)[C@@H](CO)O2)O)O1 MUPFEKGTMRGPLJ-ZQSKZDJDSA-N 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 238000011218 seed culture Methods 0.000 description 2
- 235000015500 sitosterol Nutrition 0.000 description 2
- HCXVJBMSMIARIN-PHZDYDNGSA-N stigmasterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)/C=C/[C@@H](CC)C(C)C)[C@@]1(C)CC2 HCXVJBMSMIARIN-PHZDYDNGSA-N 0.000 description 2
- 235000016831 stigmasterol Nutrition 0.000 description 2
- 229940032091 stigmasterol Drugs 0.000 description 2
- BFDNMXAIBMJLBB-UHFFFAOYSA-N stigmasterol Natural products CCC(C=CC(C)C1CCCC2C3CC=C4CC(O)CCC4(C)C3CCC12C)C(C)C BFDNMXAIBMJLBB-UHFFFAOYSA-N 0.000 description 2
- 239000000758 substrate Substances 0.000 description 2
- 239000004094 surface-active agent Substances 0.000 description 2
- OUYCCCASQSFEME-UHFFFAOYSA-N tyrosine Natural products OC(=O)C(N)CC1=CC=C(O)C=C1 OUYCCCASQSFEME-UHFFFAOYSA-N 0.000 description 2
- LUJVUUWNAPIQQI-UHFFFAOYSA-N (+)-androsta-1,4-diene-3,17-dione Natural products O=C1C=CC2(C)C3CCC(C)(C(CC4)=O)C4C3CCC2=C1 LUJVUUWNAPIQQI-UHFFFAOYSA-N 0.000 description 1
- OSELKOCHBMDKEJ-UHFFFAOYSA-N (10R)-3c-Hydroxy-10r.13c-dimethyl-17c-((R)-1-methyl-4-isopropyl-hexen-(4c)-yl)-(8cH.9tH.14tH)-Delta5-tetradecahydro-1H-cyclopenta[a]phenanthren Natural products C1C=C2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(=CC)C(C)C)C1(C)CC2 OSELKOCHBMDKEJ-UHFFFAOYSA-N 0.000 description 1
- BQPPJGMMIYJVBR-UHFFFAOYSA-N (10S)-3c-Acetoxy-4.4.10r.13c.14t-pentamethyl-17c-((R)-1.5-dimethyl-hexen-(4)-yl)-(5tH)-Delta8-tetradecahydro-1H-cyclopenta[a]phenanthren Natural products CC12CCC(OC(C)=O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C)CCC21C BQPPJGMMIYJVBR-UHFFFAOYSA-N 0.000 description 1
- MBZYKEVPFYHDOH-UHFFFAOYSA-N (10S)-3c-Hydroxy-4.4.10r.13t.14c-pentamethyl-17t-((R)-1.5-dimethyl-hexyl)-(5tH)-Delta8-tetradecahydro-1H-cyclopenta[a]phenanthren Natural products CC12CCC(O)C(C)(C)C1CCC1=C2CCC2(C)C(C(C)CCCC(C)C)CCC21C MBZYKEVPFYHDOH-UHFFFAOYSA-N 0.000 description 1
- RQOCXCFLRBRBCS-UHFFFAOYSA-N (22E)-cholesta-5,7,22-trien-3beta-ol Natural products C1C(O)CCC2(C)C(CCC3(C(C(C)C=CCC(C)C)CCC33)C)C3=CC=C21 RQOCXCFLRBRBCS-UHFFFAOYSA-N 0.000 description 1
- GMKMEZVLHJARHF-UHFFFAOYSA-N (2R,6R)-form-2.6-Diaminoheptanedioic acid Natural products OC(=O)C(N)CCCC(N)C(O)=O GMKMEZVLHJARHF-UHFFFAOYSA-N 0.000 description 1
- BBBFYZOJHSYQMW-LGDQNDJISA-N (2s)-2,4-diamino-4-oxobutanoic acid;(2r,3s,4r,5r)-2,3,4,5,6-pentahydroxyhexanal Chemical compound OC(=O)[C@@H](N)CC(N)=O.OC[C@@H](O)[C@@H](O)[C@H](O)[C@@H](O)C=O BBBFYZOJHSYQMW-LGDQNDJISA-N 0.000 description 1
- ZBFPGLKEWSMWSG-BQNIITSRSA-N (3S,5R,10S,13R,14R,17R)-4,4,10,13,14-pentamethyl-17-[(2R)-6-methylhept-5-en-2-yl]-2,3,5,6,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-3-ol Chemical compound CC1(C)[C@@H](O)CC[C@]2(C)C3=CC[C@]4(C)[C@@H]([C@@H](CCC=C(C)C)C)CC[C@@]4(C)C3=CC[C@H]21 ZBFPGLKEWSMWSG-BQNIITSRSA-N 0.000 description 1
- ZCBDFGFNCFLBOL-BQNIITSRSA-N (3S,5R,10S,13R,14R,17R)-4,4,10,13,14-pentamethyl-17-[(2R)-6-methylheptan-2-yl]-2,3,5,6,12,15,16,17-octahydro-1H-cyclopenta[a]phenanthren-3-ol Chemical compound CC1(C)[C@@H](O)CC[C@]2(C)C3=CC[C@]4(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@@]4(C)C3=CC[C@H]21 ZCBDFGFNCFLBOL-BQNIITSRSA-N 0.000 description 1
- CHGIKSSZNBCNDW-UHFFFAOYSA-N (3beta,5alpha)-4,4-Dimethylcholesta-8,24-dien-3-ol Natural products CC12CCC(O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C)CCC21 CHGIKSSZNBCNDW-UHFFFAOYSA-N 0.000 description 1
- GEYOCULIXLDCMW-UHFFFAOYSA-N 1,2-phenylenediamine Chemical compound NC1=CC=CC=C1N GEYOCULIXLDCMW-UHFFFAOYSA-N 0.000 description 1
- OWEGMIWEEQEYGQ-UHFFFAOYSA-N 100676-05-9 Natural products OC1C(O)C(O)C(CO)OC1OCC1C(O)C(O)C(O)C(OC2C(OC(O)C(O)C2O)CO)O1 OWEGMIWEEQEYGQ-UHFFFAOYSA-N 0.000 description 1
- XYTLYKGXLMKYMV-UHFFFAOYSA-N 14alpha-methylzymosterol Natural products CC12CCC(O)CC1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C)CCC21C XYTLYKGXLMKYMV-UHFFFAOYSA-N 0.000 description 1
- HIXDQWDOVZUNNA-UHFFFAOYSA-N 2-(3,4-dimethoxyphenyl)-5-hydroxy-7-methoxychromen-4-one Chemical compound C=1C(OC)=CC(O)=C(C(C=2)=O)C=1OC=2C1=CC=C(OC)C(OC)=C1 HIXDQWDOVZUNNA-UHFFFAOYSA-N 0.000 description 1
- RFVNOJDQRGSOEL-UHFFFAOYSA-N 2-hydroxyethyl octadecanoate Chemical compound CCCCCCCCCCCCCCCCCC(=O)OCCO RFVNOJDQRGSOEL-UHFFFAOYSA-N 0.000 description 1
- MBZYKEVPFYHDOH-BQNIITSRSA-N 24,25-dihydrolanosterol Chemical compound C([C@@]12C)C[C@H](O)C(C)(C)[C@@H]1CCC1=C2CC[C@]2(C)[C@@H]([C@H](C)CCCC(C)C)CC[C@]21C MBZYKEVPFYHDOH-BQNIITSRSA-N 0.000 description 1
- FPTJELQXIUUCEY-UHFFFAOYSA-N 3beta-Hydroxy-lanostan Natural products C1CC2C(C)(C)C(O)CCC2(C)C2C1C1(C)CCC(C(C)CCCC(C)C)C1(C)CC2 FPTJELQXIUUCEY-UHFFFAOYSA-N 0.000 description 1
- CQSRUKJFZKVYCY-UHFFFAOYSA-N 5alpha-isofucostan-3beta-ol Natural products C1CC2CC(O)CCC2(C)C2C1C1CCC(C(C)CCC(=CC)C(C)C)C1(C)CC2 CQSRUKJFZKVYCY-UHFFFAOYSA-N 0.000 description 1
- 239000005725 8-Hydroxyquinoline Substances 0.000 description 1
- 241000187655 Actinokineospora fastidiosa Species 0.000 description 1
- 241000186063 Arthrobacter Species 0.000 description 1
- DCXYFEDJOCDNAF-UHFFFAOYSA-N Asparagine Natural products OC(=O)C(N)CC(N)=O DCXYFEDJOCDNAF-UHFFFAOYSA-N 0.000 description 1
- 241000193830 Bacillus <bacterium> Species 0.000 description 1
- OILXMJHPFNGGTO-NRHJOKMGSA-N Brassicasterol Natural products O[C@@H]1CC=2[C@@](C)([C@@H]3[C@H]([C@H]4[C@](C)([C@H]([C@@H](/C=C/[C@H](C(C)C)C)C)CC4)CC3)CC=2)CC1 OILXMJHPFNGGTO-NRHJOKMGSA-N 0.000 description 1
- 241000186146 Brevibacterium Species 0.000 description 1
- 241000238366 Cephalopoda Species 0.000 description 1
- RYGMFSIKBFXOCR-UHFFFAOYSA-N Copper Chemical compound [Cu] RYGMFSIKBFXOCR-UHFFFAOYSA-N 0.000 description 1
- 229920002261 Corn starch Polymers 0.000 description 1
- 241000186216 Corynebacterium Species 0.000 description 1
- RFSUNEUAIZKAJO-VRPWFDPXSA-N D-Fructose Natural products OC[C@H]1OC(O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-VRPWFDPXSA-N 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- DNVPQKQSNYMLRS-NXVQYWJNSA-N Ergosterol Natural products CC(C)[C@@H](C)C=C[C@H](C)[C@H]1CC[C@H]2C3=CC=C4C[C@@H](O)CC[C@]4(C)[C@@H]3CC[C@]12C DNVPQKQSNYMLRS-NXVQYWJNSA-N 0.000 description 1
- 235000019733 Fish meal Nutrition 0.000 description 1
- RFSUNEUAIZKAJO-ARQDHWQXSA-N Fructose Chemical compound OC[C@H]1O[C@](O)(CO)[C@@H](O)[C@@H]1O RFSUNEUAIZKAJO-ARQDHWQXSA-N 0.000 description 1
- GBBBJSKVBYJMBG-QTWVXCTBSA-N Fucosterol Natural products CC=C(CC[C@@H](C)[C@@H]1CC[C@@H]2[C@H]3C=C[C@@H]4C[C@H](O)CC[C@@]4(C)[C@@H]3CC[C@@]12C)C(C)C GBBBJSKVBYJMBG-QTWVXCTBSA-N 0.000 description 1
- BKLIAINBCQPSOV-UHFFFAOYSA-N Gluanol Natural products CC(C)CC=CC(C)C1CCC2(C)C3=C(CCC12C)C4(C)CCC(O)C(C)(C)C4CC3 BKLIAINBCQPSOV-UHFFFAOYSA-N 0.000 description 1
- 239000004471 Glycine Substances 0.000 description 1
- SQUHHTBVTRBESD-UHFFFAOYSA-N Hexa-Ac-myo-Inositol Natural products CC(=O)OC1C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C(OC(C)=O)C1OC(C)=O SQUHHTBVTRBESD-UHFFFAOYSA-N 0.000 description 1
- OSELKOCHBMDKEJ-VRUYXKNBSA-N Isofucosterol Natural products CC=C(CC[C@@H](C)[C@H]1CC[C@@H]2[C@H]3CC=C4C[C@@H](O)CC[C@]4(C)[C@@H]3CC[C@]12C)C(C)C OSELKOCHBMDKEJ-VRUYXKNBSA-N 0.000 description 1
- SRBFZHDQGSBBOR-HWQSCIPKSA-N L-arabinopyranose Chemical compound O[C@H]1COC(O)[C@H](O)[C@H]1O SRBFZHDQGSBBOR-HWQSCIPKSA-N 0.000 description 1
- DCXYFEDJOCDNAF-REOHCLBHSA-N L-asparagine Chemical compound OC(=O)[C@@H](N)CC(N)=O DCXYFEDJOCDNAF-REOHCLBHSA-N 0.000 description 1
- SHZGCJCMOBCMKK-JFNONXLTSA-N L-rhamnopyranose Chemical compound C[C@@H]1OC(O)[C@H](O)[C@H](O)[C@H]1O SHZGCJCMOBCMKK-JFNONXLTSA-N 0.000 description 1
- LOPKHWOTGJIQLC-UHFFFAOYSA-N Lanosterol Natural products CC(CCC=C(C)C)C1CCC2(C)C3=C(CCC12C)C4(C)CCC(C)(O)C(C)(C)C4CC3 LOPKHWOTGJIQLC-UHFFFAOYSA-N 0.000 description 1
- FYYHWMGAXLPEAU-UHFFFAOYSA-N Magnesium Chemical compound [Mg] FYYHWMGAXLPEAU-UHFFFAOYSA-N 0.000 description 1
- GUBGYTABKSRVRQ-PICCSMPSSA-N Maltose Natural products O[C@@H]1[C@@H](O)[C@H](O)[C@@H](CO)O[C@@H]1O[C@@H]1[C@@H](CO)OC(O)[C@H](O)[C@H]1O GUBGYTABKSRVRQ-PICCSMPSSA-N 0.000 description 1
- 241000186359 Mycobacterium Species 0.000 description 1
- GXCLVBGFBYZDAG-UHFFFAOYSA-N N-[2-(1H-indol-3-yl)ethyl]-N-methylprop-2-en-1-amine Chemical compound CN(CCC1=CNC2=C1C=CC=C2)CC=C GXCLVBGFBYZDAG-UHFFFAOYSA-N 0.000 description 1
- 238000005481 NMR spectroscopy Methods 0.000 description 1
- CAHGCLMLTWQZNJ-UHFFFAOYSA-N Nerifoliol Natural products CC12CCC(O)C(C)(C)C1CCC1=C2CCC2(C)C(C(CCC=C(C)C)C)CCC21C CAHGCLMLTWQZNJ-UHFFFAOYSA-N 0.000 description 1
- CTQNGGLPUBDAKN-UHFFFAOYSA-N O-Xylene Chemical compound CC1=CC=CC=C1C CTQNGGLPUBDAKN-UHFFFAOYSA-N 0.000 description 1
- OAICVXFJPJFONN-UHFFFAOYSA-N Phosphorus Chemical compound [P] OAICVXFJPJFONN-UHFFFAOYSA-N 0.000 description 1
- 239000002202 Polyethylene glycol Substances 0.000 description 1
- ZLMJMSJWJFRBEC-UHFFFAOYSA-N Potassium Chemical compound [K] ZLMJMSJWJFRBEC-UHFFFAOYSA-N 0.000 description 1
- ORNBQBCIOKFOEO-YQUGOWONSA-N Pregnenolone Natural products O=C(C)[C@@H]1[C@@]2(C)[C@H]([C@H]3[C@@H]([C@]4(C)C(=CC3)C[C@@H](O)CC4)CC2)CC1 ORNBQBCIOKFOEO-YQUGOWONSA-N 0.000 description 1
- 241000586779 Protaminobacter Species 0.000 description 1
- 241000869142 Pseudonocardia sp. Species 0.000 description 1
- 241000187602 Pseudonocardia thermophila Species 0.000 description 1
- MUPFEKGTMRGPLJ-RMMQSMQOSA-N Raffinose Natural products O(C[C@H]1[C@@H](O)[C@H](O)[C@@H](O)[C@@H](O[C@@]2(CO)[C@H](O)[C@@H](O)[C@@H](CO)O2)O1)[C@@H]1[C@H](O)[C@@H](O)[C@@H](O)[C@@H](CO)O1 MUPFEKGTMRGPLJ-RMMQSMQOSA-N 0.000 description 1
- 241000576755 Sclerotia Species 0.000 description 1
- VYPSYNLAJGMNEJ-UHFFFAOYSA-N Silicium dioxide Chemical compound O=[Si]=O VYPSYNLAJGMNEJ-UHFFFAOYSA-N 0.000 description 1
- IOEJYZSZYUROLN-UHFFFAOYSA-M Sodium diethyldithiocarbamate Chemical compound [Na+].CCN(CC)C([S-])=S IOEJYZSZYUROLN-UHFFFAOYSA-M 0.000 description 1
- 244000061456 Solanum tuberosum Species 0.000 description 1
- 235000002595 Solanum tuberosum Nutrition 0.000 description 1
- IYFATESGLOUGBX-YVNJGZBMSA-N Sorbitan monopalmitate Chemical compound CCCCCCCCCCCCCCCC(=O)OC[C@@H](O)[C@H]1OC[C@H](O)[C@H]1O IYFATESGLOUGBX-YVNJGZBMSA-N 0.000 description 1
- 241000187747 Streptomyces Species 0.000 description 1
- KDYFGRWQOYBRFD-UHFFFAOYSA-N Succinic acid Natural products OC(=O)CCC(O)=O KDYFGRWQOYBRFD-UHFFFAOYSA-N 0.000 description 1
- CZMRCDWAGMRECN-UGDNZRGBSA-N Sucrose Chemical compound O[C@H]1[C@H](O)[C@@H](CO)O[C@@]1(CO)O[C@@H]1[C@H](O)[C@@H](O)[C@H](O)[C@@H](CO)O1 CZMRCDWAGMRECN-UGDNZRGBSA-N 0.000 description 1
- 229930006000 Sucrose Natural products 0.000 description 1
- 241000203640 Thermomonospora Species 0.000 description 1
- MUPFEKGTMRGPLJ-UHFFFAOYSA-N UNPD196149 Natural products OC1C(O)C(CO)OC1(CO)OC1C(O)C(O)C(O)C(COC2C(C(O)C(O)C(CO)O2)O)O1 MUPFEKGTMRGPLJ-UHFFFAOYSA-N 0.000 description 1
- OILXMJHPFNGGTO-ZRUUVFCLSA-N UNPD197407 Natural products C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)C=C[C@H](C)C(C)C)[C@@]1(C)CC2 OILXMJHPFNGGTO-ZRUUVFCLSA-N 0.000 description 1
- DGEZNRSVGBDHLK-UHFFFAOYSA-N [1,10]phenanthroline Chemical compound C1=CN=C2C3=NC=CC=C3C=CC2=C1 DGEZNRSVGBDHLK-UHFFFAOYSA-N 0.000 description 1
- 238000010521 absorption reaction Methods 0.000 description 1
- 239000002253 acid Substances 0.000 description 1
- 239000003463 adsorbent Substances 0.000 description 1
- ZBFPGLKEWSMWSG-UHFFFAOYSA-N agnosterone Natural products CC1(C)C(O)CCC2(C)C3=CCC4(C)C(C(CCC=C(C)C)C)CCC4(C)C3=CCC21 ZBFPGLKEWSMWSG-UHFFFAOYSA-N 0.000 description 1
- PYMYPHUHKUWMLA-VPENINKCSA-N aldehydo-D-xylose Chemical compound OC[C@@H](O)[C@H](O)[C@@H](O)C=O PYMYPHUHKUWMLA-VPENINKCSA-N 0.000 description 1
- PNNNRSAQSRJVSB-BXKVDMCESA-N aldehydo-L-rhamnose Chemical compound C[C@H](O)[C@H](O)[C@@H](O)[C@@H](O)C=O PNNNRSAQSRJVSB-BXKVDMCESA-N 0.000 description 1
- WQZGKKKJIJFFOK-PHYPRBDBSA-N alpha-D-galactose Chemical compound OC[C@H]1O[C@H](O)[C@H](O)[C@@H](O)[C@H]1O WQZGKKKJIJFFOK-PHYPRBDBSA-N 0.000 description 1
- YNQLUTRBYVCPMQ-UHFFFAOYSA-N alpha-methyl toluene Natural products CCC1=CC=CC=C1 YNQLUTRBYVCPMQ-UHFFFAOYSA-N 0.000 description 1
- PNEYBMLMFCGWSK-UHFFFAOYSA-N aluminium oxide Inorganic materials [O-2].[O-2].[O-2].[Al+3].[Al+3] PNEYBMLMFCGWSK-UHFFFAOYSA-N 0.000 description 1
- 235000019270 ammonium chloride Nutrition 0.000 description 1
- 238000004458 analytical method Methods 0.000 description 1
- LUJVUUWNAPIQQI-QAGGRKNESA-N androsta-1,4-diene-3,17-dione Chemical compound O=C1C=C[C@]2(C)[C@H]3CC[C@](C)(C(CC4)=O)[C@@H]4[C@@H]3CCC2=C1 LUJVUUWNAPIQQI-QAGGRKNESA-N 0.000 description 1
- PYMYPHUHKUWMLA-WDCZJNDASA-N arabinose Chemical compound OC[C@@H](O)[C@@H](O)[C@H](O)C=O PYMYPHUHKUWMLA-WDCZJNDASA-N 0.000 description 1
- PYMYPHUHKUWMLA-UHFFFAOYSA-N arabinose Natural products OCC(O)C(O)C(O)C=O PYMYPHUHKUWMLA-UHFFFAOYSA-N 0.000 description 1
- 229960001230 asparagine Drugs 0.000 description 1
- 235000009582 asparagine Nutrition 0.000 description 1
- 229940076810 beta sitosterol Drugs 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- OILXMJHPFNGGTO-ZAUYPBDWSA-N brassicasterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)/C=C/[C@H](C)C(C)C)[C@@]1(C)CC2 OILXMJHPFNGGTO-ZAUYPBDWSA-N 0.000 description 1
- 235000004420 brassicasterol Nutrition 0.000 description 1
- KDYFGRWQOYBRFD-NUQCWPJISA-N butanedioic acid Chemical compound O[14C](=O)CC[14C](O)=O KDYFGRWQOYBRFD-NUQCWPJISA-N 0.000 description 1
- 230000010261 cell growth Effects 0.000 description 1
- NYOXRYYXRWJDKP-GYKMGIIDSA-N cholest-4-en-3-one Chemical compound C1CC2=CC(=O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CCCC(C)C)[C@@]1(C)CC2 NYOXRYYXRWJDKP-GYKMGIIDSA-N 0.000 description 1
- NYOXRYYXRWJDKP-UHFFFAOYSA-N cholestenone Natural products C1CC2=CC(=O)CCC2(C)C2C1C1CCC(C(C)CCCC(C)C)C1(C)CC2 NYOXRYYXRWJDKP-UHFFFAOYSA-N 0.000 description 1
- 238000004587 chromatography analysis Methods 0.000 description 1
- 230000015271 coagulation Effects 0.000 description 1
- 238000005345 coagulation Methods 0.000 description 1
- GFHNAMRJFCEERV-UHFFFAOYSA-L cobalt chloride hexahydrate Chemical compound O.O.O.O.O.O.[Cl-].[Cl-].[Co+2] GFHNAMRJFCEERV-UHFFFAOYSA-L 0.000 description 1
- 229910052802 copper Inorganic materials 0.000 description 1
- 239000010949 copper Substances 0.000 description 1
- JZCCFEFSEZPSOG-UHFFFAOYSA-L copper(II) sulfate pentahydrate Chemical compound O.O.O.O.O.[Cu+2].[O-]S([O-])(=O)=O JZCCFEFSEZPSOG-UHFFFAOYSA-L 0.000 description 1
- 239000008120 corn starch Substances 0.000 description 1
- 229940099112 cornstarch Drugs 0.000 description 1
- 230000000593 degrading effect Effects 0.000 description 1
- 235000014113 dietary fatty acids Nutrition 0.000 description 1
- ZPWVASYFFYYZEW-UHFFFAOYSA-L dipotassium hydrogen phosphate Chemical compound [K+].[K+].OP([O-])([O-])=O ZPWVASYFFYYZEW-UHFFFAOYSA-L 0.000 description 1
- 229910000396 dipotassium phosphate Inorganic materials 0.000 description 1
- 235000019797 dipotassium phosphate Nutrition 0.000 description 1
- 239000003995 emulsifying agent Substances 0.000 description 1
- DNVPQKQSNYMLRS-SOWFXMKYSA-N ergosterol Chemical compound C1[C@@H](O)CC[C@]2(C)[C@H](CC[C@]3([C@H]([C@H](C)/C=C/[C@@H](C)C(C)C)CC[C@H]33)C)C3=CC=C21 DNVPQKQSNYMLRS-SOWFXMKYSA-N 0.000 description 1
- 239000002024 ethyl acetate extract Substances 0.000 description 1
- 239000000194 fatty acid Substances 0.000 description 1
- 229930195729 fatty acid Natural products 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 238000000855 fermentation Methods 0.000 description 1
- 230000004151 fermentation Effects 0.000 description 1
- 229940044631 ferric chloride hexahydrate Drugs 0.000 description 1
- 235000021323 fish oil Nutrition 0.000 description 1
- 239000004467 fishmeal Substances 0.000 description 1
- 239000000796 flavoring agent Substances 0.000 description 1
- 235000019634 flavors Nutrition 0.000 description 1
- OSELKOCHBMDKEJ-JUGJNGJRSA-N fucosterol Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H]([C@H](C)CC\C(=C/C)C(C)C)[C@@]1(C)CC2 OSELKOCHBMDKEJ-JUGJNGJRSA-N 0.000 description 1
- 229930182830 galactose Natural products 0.000 description 1
- ZCBDFGFNCFLBOL-UHFFFAOYSA-N gamma-Lanostadienol Natural products CC1(C)C(O)CCC2(C)C3=CCC4(C)C(C(C)CCCC(C)C)CCC4(C)C3=CCC21 ZCBDFGFNCFLBOL-UHFFFAOYSA-N 0.000 description 1
- 210000001647 gastrula Anatomy 0.000 description 1
- 229910001385 heavy metal Inorganic materials 0.000 description 1
- 229930195733 hydrocarbon Natural products 0.000 description 1
- 150000002430 hydrocarbons Chemical class 0.000 description 1
- 230000007062 hydrolysis Effects 0.000 description 1
- 238000006460 hydrolysis reaction Methods 0.000 description 1
- 239000012535 impurity Substances 0.000 description 1
- 230000002401 inhibitory effect Effects 0.000 description 1
- CDAISMWEOUEBRE-GPIVLXJGSA-N inositol Chemical compound O[C@H]1[C@H](O)[C@@H](O)[C@H](O)[C@H](O)[C@@H]1O CDAISMWEOUEBRE-GPIVLXJGSA-N 0.000 description 1
- 229960000367 inositol Drugs 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- NQXWGWZJXJUMQB-UHFFFAOYSA-K iron trichloride hexahydrate Chemical compound O.O.O.O.O.O.[Cl-].Cl[Fe+]Cl NQXWGWZJXJUMQB-UHFFFAOYSA-K 0.000 description 1
- CAHGCLMLTWQZNJ-RGEKOYMOSA-N lanosterol Chemical compound C([C@]12C)C[C@@H](O)C(C)(C)[C@H]1CCC1=C2CC[C@]2(C)[C@H]([C@H](CCC=C(C)C)C)CC[C@@]21C CAHGCLMLTWQZNJ-RGEKOYMOSA-N 0.000 description 1
- 229940058690 lanosterol Drugs 0.000 description 1
- 239000011777 magnesium Substances 0.000 description 1
- 229910052749 magnesium Inorganic materials 0.000 description 1
- OQTQHQORDRKHFW-UHFFFAOYSA-L manganese(2+);sulfate;heptahydrate Chemical compound O.O.O.O.O.O.O.[Mn+2].[O-]S([O-])(=O)=O OQTQHQORDRKHFW-UHFFFAOYSA-L 0.000 description 1
- 235000010355 mannitol Nutrition 0.000 description 1
- 238000004949 mass spectrometry Methods 0.000 description 1
- 235000013372 meat Nutrition 0.000 description 1
- 239000013028 medium composition Substances 0.000 description 1
- GMKMEZVLHJARHF-SYDPRGILSA-N meso-2,6-diaminopimelic acid Chemical compound [O-]C(=O)[C@@H]([NH3+])CCC[C@@H]([NH3+])C([O-])=O GMKMEZVLHJARHF-SYDPRGILSA-N 0.000 description 1
- 230000002503 metabolic effect Effects 0.000 description 1
- 239000002207 metabolite Substances 0.000 description 1
- 125000001570 methylene group Chemical group [H]C([H])([*:1])[*:2] 0.000 description 1
- 235000013379 molasses Nutrition 0.000 description 1
- 239000006916 nutrient agar Substances 0.000 description 1
- 239000006877 oatmeal agar Substances 0.000 description 1
- 150000007524 organic acids Chemical class 0.000 description 1
- 235000005985 organic acids Nutrition 0.000 description 1
- 229960003540 oxyquinoline Drugs 0.000 description 1
- 239000003208 petroleum Substances 0.000 description 1
- 229910052698 phosphorus Inorganic materials 0.000 description 1
- 239000011574 phosphorus Substances 0.000 description 1
- 229910052697 platinum Inorganic materials 0.000 description 1
- 229920001223 polyethylene glycol Polymers 0.000 description 1
- 239000000249 polyoxyethylene sorbitan monopalmitate Substances 0.000 description 1
- 235000010483 polyoxyethylene sorbitan monopalmitate Nutrition 0.000 description 1
- 239000001818 polyoxyethylene sorbitan monostearate Substances 0.000 description 1
- 235000010989 polyoxyethylene sorbitan monostearate Nutrition 0.000 description 1
- 239000011591 potassium Substances 0.000 description 1
- 229910052700 potassium Inorganic materials 0.000 description 1
- 229910000160 potassium phosphate Inorganic materials 0.000 description 1
- 235000011009 potassium phosphates Nutrition 0.000 description 1
- 230000001376 precipitating effect Effects 0.000 description 1
- ORNBQBCIOKFOEO-QGVNFLHTSA-N pregnenolone Chemical compound C1C=C2C[C@@H](O)CC[C@]2(C)[C@@H]2[C@@H]1[C@@H]1CC[C@H](C(=O)C)[C@@]1(C)CC2 ORNBQBCIOKFOEO-QGVNFLHTSA-N 0.000 description 1
- 229960000249 pregnenolone Drugs 0.000 description 1
- 229960003387 progesterone Drugs 0.000 description 1
- 239000000186 progesterone Substances 0.000 description 1
- MCJGNVYPOGVAJF-UHFFFAOYSA-N quinolin-8-ol Chemical compound C1=CN=C2C(O)=CC=CC2=C1 MCJGNVYPOGVAJF-UHFFFAOYSA-N 0.000 description 1
- 238000001953 recrystallisation Methods 0.000 description 1
- CDAISMWEOUEBRE-UHFFFAOYSA-N scyllo-inosotol Natural products OC1C(O)C(O)C(O)C(O)C1O CDAISMWEOUEBRE-UHFFFAOYSA-N 0.000 description 1
- 239000000741 silica gel Substances 0.000 description 1
- 229910002027 silica gel Inorganic materials 0.000 description 1
- 239000010802 sludge Substances 0.000 description 1
- 239000001488 sodium phosphate Substances 0.000 description 1
- 229910000162 sodium phosphate Inorganic materials 0.000 description 1
- 229940075562 sodium phosphate dihydrate Drugs 0.000 description 1
- 235000011008 sodium phosphates Nutrition 0.000 description 1
- 239000002689 soil Substances 0.000 description 1
- 229940031953 sorbitan monopalmitate Drugs 0.000 description 1
- 230000001954 sterilising effect Effects 0.000 description 1
- 238000004659 sterilization and disinfection Methods 0.000 description 1
- 150000003431 steroids Chemical class 0.000 description 1
- 239000005720 sucrose Substances 0.000 description 1
- 150000008163 sugars Chemical class 0.000 description 1
- 230000008961 swelling Effects 0.000 description 1
- 230000009897 systematic effect Effects 0.000 description 1
- 239000003784 tall oil Substances 0.000 description 1
- 229960003604 testosterone Drugs 0.000 description 1
- RYFMWSXOAZQYPI-UHFFFAOYSA-K trisodium phosphate Chemical compound [Na+].[Na+].[Na+].[O-]P([O-])([O-])=O RYFMWSXOAZQYPI-UHFFFAOYSA-K 0.000 description 1
- CRKADHVTAQCXRA-UHFFFAOYSA-K trisodium;phosphate;dihydrate Chemical compound O.O.[Na+].[Na+].[Na+].[O-]P([O-])([O-])=O CRKADHVTAQCXRA-UHFFFAOYSA-K 0.000 description 1
- 235000015112 vegetable and seed oil Nutrition 0.000 description 1
- 239000008158 vegetable oil Substances 0.000 description 1
- 238000009423 ventilation Methods 0.000 description 1
- 229940088594 vitamin Drugs 0.000 description 1
- 235000013343 vitamin Nutrition 0.000 description 1
- 239000011782 vitamin Substances 0.000 description 1
- 229930003231 vitamin Natural products 0.000 description 1
- 239000008096 xylene Substances 0.000 description 1
- RZLVQBNCHSJZPX-UHFFFAOYSA-L zinc sulfate heptahydrate Chemical compound O.O.O.O.O.O.O.[Zn+2].[O-]S([O-])(=O)=O RZLVQBNCHSJZPX-UHFFFAOYSA-L 0.000 description 1
- 239000004711 α-olefin Substances 0.000 description 1
Landscapes
- Preparation Of Compounds By Using Micro-Organisms (AREA)
Description
本発明は微生物の変換能力を使用して、発酵法
によりステロール類または、その誘導体からアン
ドロスタン系化合物を製造する方法に関するもの
である。
従来からコレステロール、スチグマステロー
ル、エルゴステロール、カンペステロール、シト
ステロール等のステロール類およびそれらのA環
における脱水素化合物(以下ステロール類と略記
する)を原料として発酵法により、アンドロスタ
−1,4−ジエン−3,17−ジオン(以下ADD
と略記する)、アンドロスト−4−エン−3,17
−ジオン(以下4ADと略記する)、17β−ヒドロ
キシアンドロスタ−1,4−ジエン−3−オン
(デヒドロテストステロン)(以下DHTと略記す
る)あるいは、17β−ヒドロキシアンドロスト−
4−エン−3−オン(テストステロン)(以下
TSNと略記する)等のA環が脱水素化されたア
ンドロスタン系化合物(以下アンドロスタン系化
合物と略記する)を得ることは既に知られてい
る。ステロール類を分解することのできる微生物
を用い、ステロール類を原料として酸化を行わせ
ると、完全分解に至るまでの代謝中間体としてア
ンドロスタン系化合物が産出される。しかしなが
ら、このような中間代謝物として生成するアンド
ロスタン系化合物は更に酸化を受け易く、培地中
に高濃度に蓄積させることは実質的に不可能であ
る。そこで生成したアンドロスタン系化合物の酸
化を阻害する方法としては、ニツケル、カドミウ
ム、コバルト等の重金属イオンの存在下に変換を
行わせる方法(特公昭46−17951号公報)や、鉄
または銅とキレート化合物を形成し得る化合物の
存在下に培養を行う方法(特公昭42−10862号公
報)などが知られている。又、他の方法として
は、野生株の有するアンドロスタン系化合物の分
解酵素のいずれかを欠失または低活性化させた突
然変異株を用いる方法(特開昭52−105289号公
報)が知られている。
本発明の目的は、ステロイド変換反応に従来ま
つたく利用されなかつたシユードノカルデイア
(Pseudonocardia)属に属する放線菌を新たな変
換菌として提供することにある。
従来、ステロール類よりアンドロスタン系化合
物を生産する能力を有する微生物としては、アル
スロバクター(Arthrobacter)属、バシルス
(Bacillus)属、ブレビバクテリウム
(Brevibacterium)属、コリネバクテリウム
(Corynebacterium)属、ミクロバクテリウム
(Microbacterium)属、ミコバクテリウム
(Mycobacterium)属、ノカルデイア
(Nocardia)属、プロタミノバクター
(Protaminobacter)属、セラチア(Seratia)属
及びストレプトミセス(Streptomyces)属など
の存在が知られているが、シユードノカルデイア
属に属する放線菌についてはその存在は全く知ら
れていない。
本発明者等は、メタノールを主たる炭素源とし
て放線菌を培養する方法について種々の研究を行
つた結果、メタノールを好んで資化するととも
に、メタノールに対する菌体収率も良好であり、
且つ、高い活性でステロール類をアンドロスタン
系化合物に変換する能力を有する放線菌を自然界
より見出し、本発明を完成するに至つた。
メタノール資化性を有するシユードノカルデイ
ア属の放線菌については既にシユードノカルデイ
ア・メタノリグニカ(Pseudonocardia methano
−lignica)及びシユードノカルデイア・ユーコ
テイス(Pseudonocardis yukotes)が知られて
いる(特開昭55−96091号公報)。
これら、メタノールを好んで資化することので
きるシユードノカルデイア属は、形態学的、生理
学的性質において極めて特徴ある性質を有してい
る。本発明は、この様な技術的背景のもとに成さ
れたものである。
本発明者等は、これらシユードノカルデイア属
を広く自然界に客め分離方法の確立を行い数多く
の菌株の分離に成功した。
本発明に用いる放線菌はシユードノカルデイ
ア・メタノリブニカに極めて類似した菌学的性質
を有するシユードノカルデイア・メタノリグニ
カ・バラエテイ・LM−145(Pseudonocardia
methanolignica variety LM−145)(微工研菌
寄第6057号)およびシユードノカルデイア・メタ
ノリグニカ・バラエテイLM−1258
(Pseudonocardia methanolignica variety LM
−1258)(微工研菌寄第6058号)によつて代表さ
れるシユードノカルデイア属である。
次に、本発明者等が分離、採集して本発明方法
に於いて用いるシユードノカルデイア・メタノリ
グニカ・バラエテイ・LM−145(以下単にLM−
145と略して記載する場合がある)、シユードノカ
ルデイア・メタノリグニカ・バラエテイ・LM−
1258(以下単にLM−1258と略して記載する場合
がある)の2菌株の菌学的性質を述べる。尚、菌
学的性質のうち特に菌種別に記載しないものは各
菌種共通の性質及び生育状態である。
A 形態学的特徴
栄養菌糸は合成培地および天然培地において
ともによく発達し、グルコース・アスパラギン
寒天平板培地で、白色の気菌糸を豊富に着生す
る。顕微鏡で観察すると、気菌糸は10個以上の
長い胞子鎖が不規則に分岐し、時にジグザグ状
に伸長し、その先端は直線状である。走査型電
子顕微鏡による観察の結果、胞子は0.4〜0.6×
1.0〜1.8ミクロンの円柱状ないし長楕円形であ
る。また、いわゆるブラストスポアを形成する
過程で、求頂的成長が認められる。胞子の表面
は平滑である。菌核、胞子のうおよび遊走子は
見出されない。
B 各種培地上に於ける性状
各種培地上に於ける性状は特に記載しない限
り37℃で14日培養後の観察である。
(1) シユークロース・硝酸塩寒天培地:
生育良好、白色気菌糸を着生する。裏面は
淡黄色を示し可溶性色素は生成しない。LM
−145菌株は若干生育が劣る。
(2) アスパラギン・グルコース寒天培地:
生育豊富、厚いカバー周辺に微弱な白色気
菌糸を着生する。裏面はうすい淡黄色を示
し、可溶性色素は生成しない。
(3) グリセリン・アスパラギン寒天培地:
生育豊富、厚いカバー状となる。LM−
1258菌株は盛り上つてシワを生ずる。周辺部
に微弱な白色気菌糸を着生し、裏面は濃い淡
黄色を示し、可溶性色素は生成しない。
(4) 澱粉・無機塩寒天培地:
生育中程度、一面に粉状の白色気菌糸を着
生、裏面は象牙色を示し、可溶性色素は生成
しない。
(5) チロシン寒天培地:
生育豊富、カバー状となり盛り上つてシワ
を生じ割れ目ができる。一面に白色気菌糸を
着生し、裏面は淡黄色を示す。LM−1258菌
株は、褐色がかつた淡黄色を示している。可
溶性色素は共に生成しない。
(6) 栄養寒天培地:
生育豊富、微弱な白色気菌糸を形成。裏面
は黄色で可溶性色素は生成しない。
(7) イースト・麦芽寒天培地:
生育豊富、コロニー表面に割れ目を生じ、
一面に白色の気菌糸を着生する。裏面は淡黄
色で可溶性色素を生成しない。
(8) オートミール寒天培地:
生育中程度、白色気菌糸を豊富に着生す
る。裏面は象牙色から黄色を示し、可溶性色
素は生成しない。
(9) グルコース・ペプトン・ゼラチン培地(28
℃):
生育豊富、盛り上つてシワを生ずる。気菌
糸は着生しない。可溶性色素は生成しない。
(10) プリドハム・ゴドリーブ寒天培地:
生育中程度、一面に白色気菌糸を着生す
る。裏面は象牙色から、うすい淡黄色を示
す。可溶性色素は生成しない。
(11) ペプトン・イースト・鉄寒天培地:
生育豊富、盛り上つた生育を示し、シワ状
となり割れ目を生ずる。気菌糸の着生はな
く、裏面は淡黄色となり、可溶性色素は生成
しない。
C 生理的性質
(1) 生育温度範囲:
25〜47℃(LM−145菌株)
25〜45℃(LM−1258菌株)
(2) 最適生育温度:
37〜44℃(LM−145菌株)
35〜43℃(LM−1258菌株)
両菌株共に43℃にても37℃と同程度または
それ以上に良好な生育を示す。
(3) ゼラチンの液化:陽性
(4) 澱粉の加水分解:陰性
(5) 脱脂乳の凝固:陰性
(6) 脱脂乳のペプトン化:陽性
(7) メラニン様色素の生成
チロシン寒天培地:陰性
ペプトン・イースト・鉄寒天培地:陰性
(8) 硝酸塩の還元能:陽性
(9) 炭素源の資化性:(プリドハム・ゴドリー
ブ寒天培地)
(a) 資化するもの:L−アラビノース、D−
キシロース、D−グルコース、D−フラク
トース、イノシトール、L−ラムノース、
D−マンニトール、メタノール、エタノー
ル、n−パラフイン
(b) 資化しないもの:シユークロース、ラフ
イノース
(10) 細胞壁の化学組成〔リツチバリアらの方法
(International Journal of Systematic
Bacteriology Vol 20、435−443(1970)に
よつた。〕
(a) 細胞壁の主要成分:ジアミノピメリン酸
はメソ型でグリシンを有せず、アラビノー
ス、ガラクトースを有する。
(b) 細胞壁のタイプ:
細胞壁組成(Cell wall type):型
糖組成(Whole cell suger patern):
A型
D 分離源:土壌
以上、上記2菌株は細胞壁組成と糖組成が型
及びA型であることから、ミコバクテリウム
(Mycobacrium)属、ノカルデイア(Nocardia)
属、ミクロポリスポーラ(Micropolyspora)属、
シユードノカルデイア(Pseudonocardia)属、
サーモモノスポラ(Thermomonospora)属のい
ずれかに属するものと考えられる。しかしなが
ら、その形態において10個以上の長い胞子鎖が不
規則に分岐し、胞子は円柱状ないしは長楕円形で
あり、その先端は直線状である。その胞子はブラ
ストスポアを形成することを特徴とすることか
ら、シユードノカルデイア(Pseudonocardia)
属とするのが妥当である(Arch.Fur
Microbiology Vol、26、373〜414(1957)参照)。
シユードノカルデイア属の既知菌種としてはシユ
ードノカルデイア・サーモフイラATCC−19285
(Pseudonocardia thermophila ATCC−19285)、
シユードノカルデイア・スピノサATCC−25924
(Pseudonocardia Spinosa ATCC−25924)、シ
ユードノカルデイア・フアスチジオサATCC−
31181(Pseudonocardia Fastidiosa ATCC−
31181)、シユードノカルデイア・メタノリグニカ
ATCC−31596(Pseudonocardia methanolignica
ATCC−31596)、シユードノカルデイア・ユウコ
テイスATCC−31597(Pseudonocardia yukotes
ATCC−31597)、シユードノカルデイア・エスピ
ーAM−3696(Pseudonocardia SP.AM−3696)
(特開昭55−115894)が知られている。本発明に
使用している菌株は生育温度範囲が25〜47℃であ
ること、メタノール及びn−パラフインを単一炭
素源として生育することが出来ること、ゼラチン
の液化及び脱脂乳のペプトン化が共に陽性である
ことなどから、シユードノカルデイア・メタノリ
グニカ(特開昭55−96091参照)と極めて類似し
た菌学的性質を有している。しかしながら、コレ
ステロール分解活性及びADD、4AD生成におい
て大きな差が認められることなどから、シユード
ノカルデイア・メタノリグニカの変種と認め、シ
ユードノカルデイア・メタノリグニカ・バラエテ
イLM−145(Pseudonocardia methanolignica
variety LM−145)、シユードノカルデイア・メ
タノリグニカ・バラエテイLM−1258
(Pseudonocardia methanolignica variety LM
−1258)と命名した。なお本菌株は工業技術院微
生物工業技術研究所に微生物受託番号微工研菌寄
第6057号(LM−145)第6058号(LM−1258)と
して寄託されている。
本発明において使用する菌株としては、上記2
菌株を好適な例として挙げることができるが、シ
ユードノカルデイア属でアンドロスタン系化合物
を蓄積する菌であればすべて用いることができ
る。
使用培地組成としては、実施例に示す如き炭素
源、窒素源、無機塩その他、使用菌の必要とする
栄養源を含む培地ならば使用可能である。
炭素源としては、n−パラフイン、α−オレフ
イン、キシレン等の炭化水素、メタノール、エタ
ノール、グリセリン、高級アルコール等のアルコ
ール類、コハク酸、酢酸、高級脂肪酸等の有機酸
およびその塩、澱粉、麦芽糖、シヨ糖、ブドウ
糖、ラムノース等の糖類があげられる。炭素源、
窒素源およびその他の栄養物質を含む天然栄養源
としては、各種糖蜜、コーンステイープリカー、
味液、魚粉、肉エキス、酵母、酵母エキス、ポテ
トエキス、麦芽エキスなどがあげられる。無機物
としては、リン酸ニカリ、リン酸−ナトリウム、
硫酸マグネシウムなどが使用できる。その他、必
要に応じてビタミン類を添加することもできる。
培地の組成は用いる菌株の種類に応じて選ばれ
るが、炭素源、窒素源、カリウム、リンおよびマ
グネシウムは培地成分として不可欠である。
消泡剤が必要な場合には周知のものを添加すれ
ばよい。
界面活性剤はステロール類の乳化剤として有効
であり、培地中に添加されることが望ましい。界
面活性剤としては、具体的にはたとえばポリオキ
シエチレンソルビタンモノステアレート、ソルビ
タンモノパルミテート、ポリエチレングリコール
モノステアレートなどを挙げることができる。
培養温度は通常25〜50℃であるが、培養温度は
37〜43℃付近が最適である。
培地のPHは通常5〜9に調整されるが6.5〜7.5
が好ましい。
本発明で原料として用いられるステロール類と
はコレステロール、スチグマステロール、カンペ
ステロール、シトステロール、エルゴステロー
ル、ブラツシカステロール、フコステロール、ラ
ノステロール、アグノステロール、ジヒドロラノ
ステロール、ジヒドロアグノステロール等が挙げ
られる。好ましいステロールはコレステロール、
カンペステロールおよびシトステロールである。
また魚油やイカ油からのアルカリ洗浄ダーク油、
さらに植物油の脱臭スカム、脱臭スラツジ、トー
ル油などのステロール含有天然物および加工物も
同様に本発明方法の原料として使用される。
さらに各種ステロールの酸化中間体も本発明の
原料として使用される。このような酸化中間体と
しては各種ステロールの4−エン−3−オン又は
1,4−ジエン−3−オン誘導体等が挙げられる
が、具体的には、たとえばコレスト−4−エン−
3−オン、コレスタ−1,4−ジエン−3−オ
ン、コレスタ−4,22−ジエン−3−オン、22,
23−ビスノルコラ−5−コレニツクアシツド−
3β−オール、22,23−ビスノルコラ−1,4−
ジエン−3−オン−22−オイツクアシツド、プレ
グネノロン、プロゲステロン等である。
本発明でアンドロスタン系化合物を培地中に高
濃度に蓄積させる為に、アンドロスタン系化合物
の酸化阻害剤を添加することが好ましい。このよ
うな酸化阻害剤としては、例えばニツケル、コバ
ルト、カドミウム等の塩類又はキレート化剤が用
いられる。キレート化剤としては、例えば2,
2′−ジピリジル、1,10−フエナントロリン、8
−ヒドロキシキノリン、クベロン、イソニコチン
酸ヒドラジトン、オルソフエニレンジアミン、
N,N−ジエチルジチオカルバミド酸ナトリウム
等を挙げることができる。これ等のキレート化剤
は2種以上を併用して用いることも可能である。
原料としてのステロール類または、その4−エ
ン−3−オンもしくは1,4−ジエン−3−オン
誘導体の添加は菌体生育後に行う。その添加濃度
は通常培地量に対し、0.5〜5g/であり1〜
3g/の範囲が好ましい。
酸化阻害剤の添加は基質の添加と同時或いは基
質添加後、数時間で行う。酸化阻害剤の添加濃度
はその種類及び培地組成によつて選択されるが、
通常培地量に対して1×10-1〜1×10-3モルが適
当である。培養は好気的条件下で行い16〜120時
間継続する。
変換反応終了後、培養液から目的物であるアン
ドロスタン系化合物の採取は一般の既知の方法が
用いられる。例えば、反応終了後の液を酢酸エチ
ル、クロロホルム、n−ヘキサン等の有機溶媒で
抽出し、抽出液から溶媒を除去したのち、シリカ
ゲル、アルミナ等の吸着剤を充填したカラムに吸
着させ、石油エーテル、ベンゼン、クロロホル
ム、酢酸エチル、エーテル、メタノール、エタノ
ール等の溶媒を用いて溶出分取する。この様にし
て溶出されたアンドロスタン系化合物は溶出液を
濃縮し、溶媒を留去したのち酢酸エチル、ベンゼ
ン等の有機溶媒から結晶化させて得られる。また
抽出物を適当に濃縮し、n−ヘキサン等で不純物
の一部を沈澱させ除去したのち、再結晶を繰返す
ことによつても得られる。
以下の実施例で、本発明をさらに詳細に説明す
るが、本発明は、その要旨を超えないかぎり、以
下の実施例に限定されない。
なお以下の実施例において、ステロール類およ
びその誘導体、アンドロスタン系化合物の定性と
定量は薄層、クロマトグラフイ、赤外吸収、核磁
気共鳴、質量分析、ガスクロマトグラフイーおよ
び高速液体クロマトグラフイーにより分析確認さ
れた。
実施例 1
グルコース10g、ポリペプトン5g、酵母エキ
ス3g、麦芽エキス3g 水1よりなる種培地
(PH7.0)100mlを500ml肩付きフラスコに分注し、
121℃、15分殺菌後、シユードノカルデイア・メ
タノリグニカバラエテイLM−145を1白金耳接
種した。40℃で約16時間通気下に振盪し、種培養
を行つた。
グルコース10g、塩化アンモニウム4g、リン
酸ニカリ7g、リン酸−ナトリウム・2水塩3
g、硫酸マグネシウム0.5g、塩化第二鉄・6水
塩1mg、硫酸銅・5水塩0.1mg、硫酸亜鉛・7水
塩0.1mg、硫酸マンガン・7水塩0.1mg、塩化コバ
ルト・6水塩1mg、酵母エキス0.03g、ポリペプ
トン1g、水1を有し、121℃で15分間殺菌さ
れた本培養培地100ml(PH7.0)を含む500mlの肩
付きフラスコに上記のようにして得られた種培養
液2mlを接種する。本培養は40℃で行い、培養開
始後18時間目に、水2mlに懸濁したステロール類
100mgを添加し、更に培養開始から24時間後に0.1
mlのメタノールに溶解させた2,2′−ジピリジル
15.62mgを添加した。2,2′−ジピリジル添加か
ら42時間後に培養を停止し、培養液を酢酸エチル
で抽出し、ガスクロマトグラフイー及び高速液体
クロマトグラフイーによりADDと4ADの生成量
を測定した。ステロール類として、コレステロー
ル、スチグマステロール、β−シトステロールと
カンペステロールの2:1混合物、コレスト−4
−エン−3−オンおよびコレスタ−1,4−ジエ
ン−3−オンを用いたときの結果を第1表に示
す。
The present invention relates to a method for producing androstane compounds from sterols or derivatives thereof by fermentation using the conversion ability of microorganisms. Conventionally, androsta-1,4- Diene-3,17-dione (hereinafter referred to as ADD)
), androst-4-ene-3,17
-dione (hereinafter abbreviated as 4AD), 17β-hydroxyandrosta-1,4-dien-3-one (dehydrotestosterone) (hereinafter abbreviated as DHT), or 17β-hydroxyandrost-1,4-dien-3-one (dehydrotestosterone) (hereinafter abbreviated as DHT)
4-en-3-one (testosterone) (hereinafter
It is already known to obtain androstane-based compounds (hereinafter abbreviated as androstane-based compounds) in which the A ring is dehydrogenated, such as (abbreviated as TSN). When sterols are oxidized using microorganisms that can decompose them, androstane compounds are produced as metabolic intermediates until complete decomposition. However, androstane compounds produced as intermediate metabolites are more susceptible to oxidation, and it is virtually impossible to accumulate them in a medium at a high concentration. Methods of inhibiting the oxidation of the androstane-based compounds generated therein include a method of converting them in the presence of heavy metal ions such as nickel, cadmium, and cobalt (Japanese Patent Publication No. 17951/1983), and a method of chelating them with iron or copper. A method of culturing in the presence of a compound capable of forming a compound (Japanese Patent Publication No. 10862/1986) is known. As another method, a method using a mutant strain in which one of the androstane compound degrading enzymes possessed by the wild strain is deleted or has low activity is known (Japanese Unexamined Patent Publication No. 105289/1989). ing. An object of the present invention is to provide actinomycetes belonging to the genus Pseudonocardia, which have not been widely used in steroid conversion reactions, as new converting bacteria. Conventionally, microorganisms that have the ability to produce androstane compounds from sterols include the genus Arthrobacter, the genus Bacillus, the genus Brevibacterium, the genus Corynebacterium, and the genus Microbacterium. The existence of genera such as Microbacterium, Mycobacterium, Nocardia, Protaminobacter, Seratia, and Streptomyces is known. However, the existence of actinomycetes belonging to the genus Pseudonochaldeia is completely unknown. The present inventors conducted various studies on methods for culturing actinomycetes using methanol as the main carbon source, and as a result, they found that they prefer to assimilate methanol, and the bacterial cell yield relative to methanol is also good.
In addition, actinomycetes were discovered in nature that have the ability to convert sterols into androstane compounds with high activity, leading to the completion of the present invention. Regarding the actinomycetes of the genus Pseudonocardia that can assimilate methanol, Pseudonocardia methanolignica (Pseudonocardia methano
-lignica) and Pseudonocardia yukotes (Japanese Unexamined Patent Publication No. 55-96091). These species of the genus Pseudonochaldeia, which are able to preferentially assimilate methanol, have extremely distinctive morphological and physiological properties. The present invention was made against this technical background. The present inventors have widely used the genus Seudonochaldeia in the natural world, established an isolation method, and succeeded in isolating a large number of strains. The actinomycetes used in the present invention are Pseudonocardia var. LM-145 (Pseudonocardia var.
methanolignica variety LM-145) (Feikoken Bacteria No. 6057) and Pseudonochaldeia methanolignica variety LM-1258
(Pseudonocardia methanolignica variety LM
-1258) (Feikoken Bibori No. 6058) is a genus of Pseudonochaldeia. Next, the present inventors isolated and collected Pseudonochaldeia methanolignica variety LM-145 (hereinafter simply LM-145) to be used in the method of the present invention.
(sometimes abbreviated as 145), Pseudonochaldeia methanolignica variety LM-
The mycological properties of two strains of 1258 (hereinafter sometimes simply referred to as LM-1258) will be described. It should be noted that among mycological properties, those not specifically described by bacterial species are properties and growth conditions common to each bacterial species. A. Morphological characteristics Vegetative hyphae develop well on both synthetic and natural media, and abundant white aerial hyphae are attached on glucose-asparagine agar plates. When observed under a microscope, aerial hyphae consist of 10 or more long spore chains that branch irregularly, sometimes elongating in a zigzag pattern, and their tips are straight. As a result of observation using a scanning electron microscope, spores are 0.4 to 0.6×
It has a cylindrical or oblong shape of 1.0 to 1.8 microns. In addition, crestal growth is observed in the process of forming so-called blast spores. The surface of the spore is smooth. No sclerotia, sporangia and zoospores are found. B Properties on various media Properties on various media were observed after culturing at 37°C for 14 days unless otherwise specified. (1) Seuculose/nitrate agar medium: Good growth, with white aerial mycelia attached. The back side shows a pale yellow color and no soluble pigment is produced. LM
-145 strain has slightly inferior growth. (2) Asparagine-glucose agar medium: Abundant growth, with faint white aerial mycelia growing around the thick cover. The back side shows a pale yellow color and no soluble pigment is produced. (3) Glycerin/asparagine agar medium: Produces abundant growth and forms a thick cover. LM−
The 1258 strain causes swelling and wrinkles. Faint white aerial hyphae grow on the periphery, and the underside is deep pale yellow, and no soluble pigment is produced. (4) Starch/inorganic salt agar medium: Medium growth, powdery white aerial mycelia are grown on one side, the back side is ivory-colored, and no soluble pigment is produced. (5) Tyrosine agar medium: It grows abundantly, forms a cover and swells, wrinkles and cracks form. White aerial mycelium grows on one side, and the underside is pale yellow. The LM-1258 strain exhibits a pale yellow color with a hint of brown. Soluble dyes are not produced together. (6) Nutrient agar medium: Abundant growth, forming faint white aerial hyphae. The back side is yellow and no soluble pigment is produced. (7) Yeast/malt agar medium: Abundant growth, cracks appear on the colony surface,
White aerial mycelium grows on the whole surface. The underside is pale yellow and does not produce soluble pigments. (8) Oatmeal agar medium: Medium growth, abundant white aerial mycelium. The underside is ivory to yellow in color and produces no soluble pigment. (9) Glucose-peptone-gelatin medium (28
℃): Abundant growth, bulges and wrinkles. Aerial mycelium does not grow. No soluble dyes are produced. (10) Pridham-Godelive agar medium: Medium growth, with white aerial mycelia growing all over. The underside is ivory to pale yellow. No soluble dyes are produced. (11) Peptone yeast iron agar medium: Abundant growth, showing mounded growth, wrinkled and cracked. There is no aerial mycelium, the underside is pale yellow, and no soluble pigment is produced. C Physiological properties (1) Growth temperature range: 25-47℃ (LM-145 strain) 25-45℃ (LM-1258 strain) (2) Optimal growth temperature: 37-44℃ (LM-145 strain) 35-45℃ 43°C (LM-1258 strain) Both strains show growth at 43°C as good or better than at 37°C. (3) Liquefaction of gelatin: Positive (4) Hydrolysis of starch: Negative (5) Coagulation of skim milk: Negative (6) Peptonization of skim milk: Positive (7) Production of melanin-like pigment Tyrosine agar medium: Negative Peptone・Yeast/iron agar medium: Negative (8) Nitrate reducing ability: Positive (9) Carbon source assimilation ability: (Pridham-Godelive agar medium) (a) Assimilated: L-arabinose, D-
xylose, D-glucose, D-fructose, inositol, L-rhamnose,
D-mannitol, methanol, ethanol, n-paraffin (b) Non-assimilable substances: seuculose, raffinose (10) Chemical composition of cell wall [method of Rittibaria et al. (International Journal of Systematic
Bacteriology Vol 20, 435-443 (1970). (a) Main component of cell wall: Diaminopimelic acid is meso-type and does not contain glycine, but contains arabinose and galactose. (b) Cell wall type: Cell wall type: Whole cell sugar pattern:
Type A D Isolation source: Soil As mentioned above, since the above two strains have cell wall composition and sugar composition of type A and type A, they belong to the genus Mycobacrium and Nocardia.
Genus, Micropolyspora,
Genus Pseudonocardia,
It is thought to belong to the genus Thermomonospora. However, in its morphology, 10 or more long spore chains are irregularly branched, and the spores are cylindrical or oblong, with straight tips. Pseudonocardia, because its spores are characterized by the formation of blastopores.
It is appropriate to consider it as a genus (Arch.Fur
Microbiology Vol, 26, 373-414 (1957)).
A known bacterial species of the genus Seudonochaldeia is Seudonochaldeia thermophila ATCC-19285.
(Pseudonocardia thermophila ATCC−19285),
Syudonochaldeia spinosa ATCC−25924
(Pseudonocardia spinosa ATCC−25924), Pseudonocardia spinosa ATCC−
31181 (Pseudonocardia Fastidiosa ATCC−
31181), Pseudonochaldeia methanolignica
ATCC−31596 (Pseudonocardia methanolignica
ATCC-31596), Pseudonocardia yukotes ATCC-31597 (Pseudonocardia yukotes)
ATCC-31597), Pseudonocardia SP.AM-3696
(Japanese Unexamined Patent Publication No. 115894, 1982) is known. The strain used in the present invention has a growth temperature range of 25 to 47°C, can grow using methanol and n-paraffin as a single carbon source, and can liquefy gelatin and peptonize skim milk. Since it is positive, it has very similar mycological properties to S. methanolignica (see JP-A-55-96091). However, since there were large differences in cholesterol decomposition activity and ADD and 4AD production, it was recognized as a variant of Pseudonocardia methanolignica, and Pseudonocardia methanolignica var. LM-145 (Pseudonocardia methanolignica var. LM-145)
variety LM-145), Pseudonochaldeia methanolignica variety LM-1258
(Pseudonocardia methanolignica variety LM
−1258). This strain has been deposited with the Institute of Microbial Technology, Agency of Industrial Science and Technology under microbial accession number 6057 (LM-145) and 6058 (LM-1258). The strains used in the present invention include the above-mentioned 2
Bacterial strains can be cited as preferred examples, but any bacterium belonging to the genus Pseudonochaldeia that accumulates androstane compounds can be used. As for the composition of the medium used, any medium can be used as long as it contains a carbon source, a nitrogen source, an inorganic salt, and other nutrient sources required by the bacteria used as shown in the examples. Carbon sources include hydrocarbons such as n-paraffin, α-olefin, and xylene, alcohols such as methanol, ethanol, glycerin, and higher alcohols, organic acids and their salts such as succinic acid, acetic acid, and higher fatty acids, starch, and maltose. Examples include sugars such as sucrose, glucose, and rhamnose. carbon source,
Natural sources of nutrients, including nitrogen sources and other nutrients, include various types of molasses, cornstarch liquor,
Examples include flavor liquid, fish meal, meat extract, yeast, yeast extract, potato extract, and malt extract. Inorganic substances include dipotassium phosphate, sodium phosphate,
Magnesium sulfate etc. can be used. In addition, vitamins can be added as necessary. The composition of the medium is selected depending on the type of bacterial strain used, but a carbon source, nitrogen source, potassium, phosphorus, and magnesium are essential components of the medium. If an antifoaming agent is required, a known antifoaming agent may be added. Surfactants are effective as emulsifiers for sterols, and are preferably added to the culture medium. Specific examples of the surfactant include polyoxyethylene sorbitan monostearate, sorbitan monopalmitate, and polyethylene glycol monostearate. The culture temperature is usually 25 to 50℃;
The optimum temperature is around 37-43℃. The pH of the medium is usually adjusted to 5-9, but it should be 6.5-7.5.
is preferred. Sterols used as raw materials in the present invention include cholesterol, stigmasterol, campesterol, sitosterol, ergosterol, brassicasterol, fucosterol, lanosterol, agnosterol, dihydrolanosterol, dihydroagnosterol, and the like. Preferred sterols are cholesterol,
campesterol and sitosterol.
Also alkaline washed dark oils from fish oil and squid oil,
Furthermore, sterol-containing natural and processed products, such as deodorized scum of vegetable oils, deodorized sludge, and tall oil, are likewise used as raw materials in the process of the invention. Furthermore, oxidized intermediates of various sterols can also be used as raw materials in the present invention. Examples of such oxidation intermediates include 4-en-3-one or 1,4-dien-3-one derivatives of various sterols, and specifically, for example, cholest-4-en-
3-one, cholesta-1,4-dien-3-one, cholesta-4,22-dien-3-one, 22,
23-bisnorcholar-5-cholenic acid-
3β-ol, 22,23-bisnorchola-1,4-
These include diene-3-one-22-oic acid, pregnenolone, and progesterone. In the present invention, it is preferable to add an oxidation inhibitor of androstane compounds in order to accumulate the androstane compounds in the medium at a high concentration. As such an oxidation inhibitor, for example, salts such as nickel, cobalt, cadmium, etc. or chelating agents are used. Examples of chelating agents include 2,
2'-dipyridyl, 1,10-phenanthroline, 8
-Hydroxyquinoline, cuberone, isonicotinic acid hydrazitone, orthophenylenediamine,
Examples include sodium N,N-diethyldithiocarbamate. It is also possible to use two or more of these chelating agents in combination. The addition of sterols or their 4-en-3-one or 1,4-dien-3-one derivatives as raw materials is carried out after bacterial cell growth. Its concentration is usually 0.5 to 5 g/1 to 1 to 5 g per medium volume.
A range of 3g/ is preferred. The oxidation inhibitor is added simultaneously with the addition of the substrate or several hours after the addition of the substrate. The concentration of the oxidation inhibitor added is selected depending on the type and medium composition;
A suitable amount is 1×10 −1 to 1×10 −3 mol based on the amount of normal medium. Cultivation is performed under aerobic conditions and lasts for 16-120 hours. After the conversion reaction is completed, a commonly known method is used to collect the target androstane compound from the culture solution. For example, after the reaction is completed, the liquid is extracted with an organic solvent such as ethyl acetate, chloroform, or n-hexane, and after removing the solvent from the extract, it is adsorbed on a column packed with an adsorbent such as silica gel or alumina, and then petroleum ether , elute and fractionate using a solvent such as benzene, chloroform, ethyl acetate, ether, methanol, or ethanol. The androstane compound eluted in this manner is obtained by concentrating the eluate, distilling off the solvent, and then crystallizing it from an organic solvent such as ethyl acetate or benzene. It can also be obtained by appropriately concentrating the extract, precipitating and removing some of the impurities with n-hexane, etc., and then repeating recrystallization. The present invention will be explained in more detail in the following examples, but the present invention is not limited to the following examples unless it exceeds the gist thereof. In the following examples, sterols, their derivatives, and androstane compounds were qualitatively and quantitatively determined by thin layer, chromatography, infrared absorption, nuclear magnetic resonance, mass spectrometry, gas chromatography, and high performance liquid chromatography. Analysis confirmed. Example 1 100 ml of a seed medium (PH7.0) consisting of 10 g of glucose, 5 g of polypeptone, 3 g of yeast extract, 1 g of malt extract, and 1 part of water was dispensed into a 500 ml flask with a shoulder.
After sterilization at 121°C for 15 minutes, one platinum loop of Pseudonochaldeia methanolignica variety LM-145 was inoculated. Seed culture was performed by shaking at 40°C for about 16 hours under ventilation. Glucose 10g, Ammonium chloride 4g, Potassium phosphate 7g, Sodium phosphate dihydrate 3
g, magnesium sulfate 0.5g, ferric chloride hexahydrate 1mg, copper sulfate pentahydrate 0.1mg, zinc sulfate heptahydrate 0.1mg, manganese sulfate heptahydrate 0.1mg, cobalt chloride hexahydrate Seeds obtained as above were placed in a 500 ml shouldered flask containing 100 ml of main culture medium (PH 7.0) containing 1 mg of yeast extract, 0.03 g of yeast extract, 1 g of polypeptone, 1 portion of water and sterilized for 15 minutes at 121°C. Inoculate 2 ml of culture. The main culture was carried out at 40℃, and 18 hours after the start of culture, sterols suspended in 2 ml of water were added.
Add 100 mg, and then add 0.1 ml after 24 hours from the start of culture.
2,2'-dipyridyl dissolved in ml methanol
15.62mg was added. The culture was stopped 42 hours after the addition of 2,2'-dipyridyl, the culture solution was extracted with ethyl acetate, and the amounts of ADD and 4AD produced were measured by gas chromatography and high performance liquid chromatography. Sterols include cholesterol, stigmasterol, a 2:1 mixture of β-sitosterol and campesterol, and cholesterol-4.
Table 1 shows the results when -en-3-one and cholesta-1,4-dien-3-one were used.
【表】
実施例 2
実施例1と同じようにして種培養したシユード
ノカルデイア・メタノリグニカバラエテイLM−
145の培養液2mlを実施例1に示した本培養培地
のグルコースをメタノール1%に置き換えた培地
100mlに接種する。40℃で培養が行われ、培養開
始後48時間目にコレステロール200mgを、培養開
始後54時間目に2,2′−ジピリジル15.62mgを添
加した。2,2′−ジピリジル添加から16時間後に
培養を停止した。その後実施例1と同じようにし
てADDと4ADの生成量を測定したところ、ADD
が18mg、4ADが9.5mg生成していた。
実施例 3
シユードノカルデイア・メタノリグニカ・バラ
エテイLM−1258を実施例1に示した方法によ
り、種培養及び本培養を行ない、培養開始後18時
間目にコレステロール100mgを添加し、さらに24
時間目に2,2′−ジピリジル15.62mgを添加した。
2,2′−ジピリジル添加から72時間後に培養を停
止し、酢酸エチル抽出物のアンドロスタン系化合
物の測定を行つたところ、ADDが15.8mg、4AD
が16.4mg、DHTが4.4mg及びTSNが3.9mg生成し
ていた。[Table] Example 2 Eudonochaldeia methanolignica variety LM-, which was seed cultured in the same manner as in Example 1.
A medium in which 2 ml of the culture solution of 145 was substituted with 1% methanol for the glucose in the main culture medium shown in Example 1.
Inoculate 100ml. Culture was carried out at 40°C, and 200 mg of cholesterol was added 48 hours after the start of culture, and 15.62 mg of 2,2'-dipyridyl was added 54 hours after the start of culture. The culture was stopped 16 hours after the addition of 2,2'-dipyridyl. After that, the production amounts of ADD and 4AD were measured in the same manner as in Example 1, and it was found that ADD
It produced 18 mg and 9.5 mg of 4AD. Example 3 Seed culture and main culture of Pseudonochaldeia methanolignica var. LM-1258 were carried out according to the method shown in Example 1, and 100 mg of cholesterol was added 18 hours after the start of culture, and further cultured for 24 hours.
At hour 15.62 mg of 2,2'-dipyridyl was added.
The culture was stopped 72 hours after the addition of 2,2'-dipyridyl, and the amount of androstane compounds in the ethyl acetate extract was measured.
16.4mg of DHT, 4.4mg of DHT, and 3.9mg of TSN were produced.
Claims (1)
誘導体をアンドロスタン系化合物に変換する能力
を有するシユードノカルデイア属の微生物を培養
し、該微生物によりステロール類又はそのA環に
おける脱水素化誘導体をアンドロスタン系化合物
に変換し、採取することを特徴とする微生物によ
るアンドロスタン系化合物の製造方法。 2 微生物がシユードノカルデイア・メタノリグ
ニカ・バラエテイ・LM−145またはシユードノ
カルデイア・メタノリグニカ・バラエテイ・LM
−1258であることを特徴とする特許請求の範囲第
1項記載の方法。 3 アンドロスタン系化合物が、アンドロスタ−
1,4−ジエン−3,17−ジオン、アンドロスト
−4−エン−3,17−ジオン、17,β−ヒドロキ
シアンドロスタ−1,4−ジエン−3−オン、
17,β−ヒドロキシアンドロスト−4−エン−3
−オンであることを特徴とする特許請求の範囲第
1項または第2項記載の方法。[Scope of Claims] 1. A microorganism of the genus Eudonocardia having the ability to convert sterols or a dehydrogenated derivative in the A ring thereof into an androstane compound is cultivated, 1. A method for producing an androstane compound using a microorganism, the method comprising converting a dehydrogenated derivative into an androstane compound and collecting the same. 2 The microorganism is Pseudonochaldeia methanolignica var. LM-145 or Pseudonochaldeia methanolignica var. LM-145
-1258. 3 Androstane-based compounds are
1,4-diene-3,17-dione, androst-4-ene-3,17-dione, 17,β-hydroxyandrost-1,4-dien-3-one,
17, β-hydroxyandrost-4-ene-3
3. The method according to claim 1 or 2, characterized in that - on.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP14109781A JPS5843796A (en) | 1981-09-09 | 1981-09-09 | Preparation of androstane compound by microorganism |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP14109781A JPS5843796A (en) | 1981-09-09 | 1981-09-09 | Preparation of androstane compound by microorganism |
Publications (2)
Publication Number | Publication Date |
---|---|
JPS5843796A JPS5843796A (en) | 1983-03-14 |
JPH0120878B2 true JPH0120878B2 (en) | 1989-04-18 |
Family
ID=15284115
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP14109781A Granted JPS5843796A (en) | 1981-09-09 | 1981-09-09 | Preparation of androstane compound by microorganism |
Country Status (1)
Country | Link |
---|---|
JP (1) | JPS5843796A (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
JPS58138380A (en) * | 1982-02-12 | 1983-08-17 | Dainippon Ink & Chem Inc | Microorganism |
JPS58138396A (en) * | 1982-02-12 | 1983-08-17 | Dainippon Ink & Chem Inc | Production of androstanes by use of microorganism |
-
1981
- 1981-09-09 JP JP14109781A patent/JPS5843796A/en active Granted
Also Published As
Publication number | Publication date |
---|---|
JPS5843796A (en) | 1983-03-14 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US4035236A (en) | Process for preparing 9α-hydroxyandrostenedione | |
US3759791A (en) | Selective microbiological preparation of androst-4-ene-3,17-dione | |
US4029549A (en) | Process of producing 9α-hydroxy-3-ketobisnorchol-4-en-22-oic with mycobacterium fortuitum | |
US4345029A (en) | Mycobacterium phlei mutants convert sterols to androsta-1,4-diene-3,17-dione and androsta-4-ene-3,17-dione | |
JPH022395A (en) | Microbiological production of 9 alpha-hydroxy- 17-ketosteroid | |
EP0011235B1 (en) | 9-alpha-hydroxy-3-oxopregna-4,17(20)-diene-20-carboxylic acid and its methyl ester and methods for the microbiological production thereof | |
US4397947A (en) | Microbial process for 9α-hydroxylation of steroids | |
US4293644A (en) | Process for preparing androst-4-ene-3,17-dione | |
US4039381A (en) | Composition of matter and process | |
US4062729A (en) | Microbial transformation of steroids | |
JPH0120878B2 (en) | ||
US4520102A (en) | Microbial process for producing 12α-hydroxypregna-1,4-dien-3-one-20α-carboxylic acid | |
US4042459A (en) | Composition of matter and process | |
US4175006A (en) | Composition of matter and process | |
US4062880A (en) | 9α-Hydroxy-bis-nor-cholanic acid | |
US4304860A (en) | Process for the microbial transformation of steroids | |
US4345030A (en) | Microorganism mutant conversion of sterols to androsta-4-ene-3,17-dione | |
EP0008214B1 (en) | Microorganisms and their use in producing androst-4-ene-3,17-dione | |
US4214051A (en) | Process for preparing 9α-OH BN acid methyl ester | |
US4329432A (en) | Mycobacterium fortuitum strain | |
US4097335A (en) | Microbial transformation of steroids | |
US4211841A (en) | Process for microbial transformation of steroids | |
US4177106A (en) | Process for preparing 3aα-H-4α-[3'-propanol]-7aβ-methylhexahydro-1,5-indanedione hemiketal | |
US4226936A (en) | Process for preparing 9α-OH BN alcohol | |
US4214052A (en) | Process for preparing 9α-OH BN alcohol |